Pharma

Your Article Summary

See Latest Articles

Medtronic Completes Enrollment in International Post-Market Study of Resolute Drug-Eluting Stent
Medtronic, 05/15/09

Medtronic, Inc. announced completion of enrollment in RESOLUTE International, a post-market study of its Resolute Drug-Eluting Stent. One-year data from this international study, which enrolled 2,464 patients at 88 sites from 17 countries in Europe, Asia, Africa, and Latin America, are expected in the second half of 2010.

Today in M&A/Partnerships...keeping you current

Receive free subspecialty "5-minute updates" via email

Omnicell Gets Cabinet Deal in Carolinas
HealthDataManagement, 12/16/09

Array BioPharma and Amgen Partner in Type 2 Diabetes
Amgen, 12/15/09

Inno Biologics and CEVEC Sign License Agreement for Human CAP Technology
b3c newswire, 12/09/09

 See all of M&A/Partnerships

Today in Marketing/Media/ROI...keeping you current

Receive free subspecialty "5-minute updates" via email

Personalized Medicine Market To Grow 11% Annually
PharmExec, 12/16/09

Human genome sciences announces submission of marketing authorization application to emea for joulferon
Human Genome Sciences, 12/16/09

Alcon to Enter Surgical Glaucoma Market by Acquiring Optonol
Alcon, 12/15/09

 See all of Marketing/Media/ROI